Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant biliary obstruction: the first case series
1
Issued Date
2022-02-01
Resource Type
ISSN
09302794
eISSN
14322218
Scopus ID
2-s2.0-85101589831
Pubmed ID
33625590
Journal Title
Surgical Endoscopy
Volume
36
Issue
2
Start Page
1117
End Page
1122
Rights Holder(s)
SCOPUS
Bibliographic Citation
Surgical Endoscopy Vol.36 No.2 (2022) , 1117-1122
Suggested Citation
Rugivarodom M. Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant biliary obstruction: the first case series. Surgical Endoscopy Vol.36 No.2 (2022) , 1117-1122. 1122. doi:10.1007/s00464-021-08378-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/86193
Title
Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant biliary obstruction: the first case series
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Background: EUS-guided hepaticoesophagostomy (EUS-HES) was reported as an alternative procedure when puncture through the esophagus was inevitable. However, the existing data is very limited. We aimed to evaluate the efficacy and safety of EUS-HES in patients with difficult malignant biliary obstruction. Methods: All cases who underwent EUS-HES at our institute were retrospectively reviewed. Results: A total of 11 patients underwent EUS-HES from January 2011 to December 2017. Five were male, and the mean age was 57.9 ± 6.3 years. The majority of the patients (8 out of 11 patients) had a biliary obstruction caused by cholangiocarcinoma. The technical success was 100%. The mean procedure time was 73.2 ± 37.6 min. The main reason for EUS-HES was the improper alignment of the bile duct due to left lobe hypertrophy. The clinical success was 90.9%. The mean overall survival was 97.8 ± 68.5 days. No major procedure-related complication, particularly pneumomediastinum, occurred. Conclusions: EUS-HES is a technically feasible and safe procedure to provide biliary drainage, especially in patients with left hepatic lobe hypertrophy. Using a bougie dilator instead of balloon dilation can avoid previously reported complications.